Leslie D. Funtleyder - 01 Jan 2026 Form 4 Insider Report for Applied Therapeutics, Inc. (APLT)

Role: Chief Financial Officer, Director
Signature: /s/ Leslie D. Funtleyder
Issuer symbol: APLT
Transactions as of: 01 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 02 Jan 2026, 18:26:36 UTC
Previous filing: 03 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Funtleyder Leslie D.	Chief Financial Officer, Director	C/O APPLIED THERAPEUTICS, INC., 545 FIFTH AVENUE, SUITE 1400, NEW YORK	/s/ Leslie D. Funtleyder	02 Jan 2026	0001775394

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APLT	Common Stock	Award	$0	+150,000	+13%	$0.000000	1,340,459	01 Jan 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of compensatory Restricted Stock Units ("RSUs") granted under the Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan (the "Plan"). Each compensatory RSU represents a contingent right to receive one share of the Issuer's common stock. The compensatory RSUs shall vest in equal monthly installments over the twenty-four month period immediately following January 1, 2026, subject to the Reporting Person continuing to provide services through each such date.

Content

Consists of compensatory Restricted Stock Units ("RSUs") granted under the Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan (the "Plan"). Each compensatory RSU represents a contingent right to receive one share of the Issuer's common stock. The compensatory RSUs shall vest in equal monthly installments over the twenty-four month period immediately following January 1, 2026, subject to the Reporting Person continuing to provide services through each such date.